NB
Namita Bansal
About Namita Bansal
Data last updated:
Namita Bansal was a Director at Solis Pharmachem Private Limited (2022–2023) and Whole-Time Director at Therachem Research Medilab (India) Private Limited (2009–2023). The companies operate in Chemicals and Materials and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Solis Pharmachem Private Limited U24100GJ2019PTC111161 | Director | 18 Apr 2022 | 2019 | ₹4.25 Cr (FY 2023) | Amalgamated |
 Therachem Research Medilab (India) Private Limited U24232RJ2006PTC023466 | Whole-Time Director | 05 Jun 2009 | 2006 | ₹194 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Namita Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namita Bansal
Namita Bansal was first appointed on 05 Jun 2009 as Whole-Time Director at Therachem Research Medilab (India) Private Limited. The most recent appointment on record is 18 Apr 2022 at Solis Pharmachem Private Limited.
Namita Bansal held 2 earlier board appointments: Solis Pharmachem Private Limited (Director, 18 Apr 2022 to 02 Jun 2023); Therachem Research Medilab (India) Private Limited (Whole-Time Director, 05 Jun 2009 to 02 Jun 2023).